Cargando…

Targeting the I7L Protease: A Rational Design for Anti-Monkeypox Drugs?

The latest monkeypox virus outbreak in 2022 showcased the potential threat of this viral zoonosis to public health. The lack of specific treatments against this infection and the success of viral protease inhibitors-based treatments against HIV, Hepatitis C, and SARS-CoV-2, brought the monkeypox vir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dodaro, Andrea, Pavan, Matteo, Moro, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138331/ https://www.ncbi.nlm.nih.gov/pubmed/37108279 http://dx.doi.org/10.3390/ijms24087119

Ejemplares similares

Thermal titration molecular dynamics (TTMD): shedding light on the stability of RNA-small molecule complexes
por: Dodaro, Andrea, et al.
Publicado: (2023)

Rational design of thioamide peptides as selective inhibitors of cysteine protease cathepsin L
por: Phan, Hoang Anh T., et al.
Publicado: (2021)

Rational design of potent anti-COVID-19 main protease drugs: An extensive multi-spectrum in silico approach
por: Ahmad, Sajjad, et al.
Publicado: (2021)

Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir
por: Bolcato, Giovanni, et al.
Publicado: (2020)

Repurposing Anti-Dengue Compounds against Monkeypox Virus Targeting Core Cysteine Protease
por: Imran, Mohd, et al.
Publicado: (2023)

Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?
por: Pavan, Matteo, et al.
Publicado: (2022)

Rational drug design
por: Truhlar, Donald, et al.
Publicado: (1999)

Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332
por: Pavan, Matteo, et al.
Publicado: (2021)

Enhancing the promiscuity of a member of the Caspase protease family by rational design
por: Öhlknecht, Christoph, et al.
Publicado: (2020)

Mycobacterium tuberculosis Shikimate Pathway Enzymes as Targets for the Rational Design of Anti-Tuberculosis Drugs
por: Nunes, José E. S., et al.
Publicado: (2020)

Re-Exploring the Ability of Common Docking Programs to Correctly Reproduce the Binding Modes of Non-Covalent Inhibitors of SARS-CoV-2 Protease M(pro)
por: Bassani, Davide, et al.
Publicado: (2022)

Structure of monkeypox virus poxin: implications for drug design
por: Duchoslav, Vojtech, et al.
Publicado: (2023)

TRPV1: A Target for Rational Drug Design
por: Carnevale, Vincenzo, et al.
Publicado: (2016)

Discovery and Rational Design of a Novel Bowman-Birk Related Protease Inhibitor
por: Miao, Yuxi, et al.
Publicado: (2019)

Improving the catalytic activity of a detergent‐compatible serine protease by rational design
por: Wang, Xiao, et al.
Publicado: (2023)

Thermal stabilization of the deglycating enzyme Amadoriase I by rational design
por: Rigoldi, Federica, et al.
Publicado: (2018)

Computational Approaches to the Rational Design of Tubulin-Targeting Agents
por: Pérez-Peña, Helena, et al.
Publicado: (2023)

Drug and Anti-Viral Peptide Design to Inhibit the Monkeypox Virus by Restricting A36R Protein
por: Miah, Mohammad Mohasin, et al.
Publicado: (2022)

Exploring the RNA-Recognition Mechanism Using Supervised Molecular Dynamics (SuMD) Simulations: Toward a Rational Design for Ribonucleic-Targeting Molecules?
por: Bissaro, Maicol, et al.
Publicado: (2020)

Molecular targets for the rational design of drugs to inhibit SARS coronavirus
por: Brockway, Sarah M., et al.
Publicado: (2004)

Identification of potential edible mushroom as SARS-CoV-2 main protease inhibitor using rational drug designing approach
por: Sen, Debanjan, et al.
Publicado: (2022)

Drug Targets for Cardiovascular-Safe Anti-Inflammatory: In Silico Rational Drug Studies
por: Shahbazi, Sajad, et al.
Publicado: (2016)

Rational Approaches to Improving Selectivity in Drug Design
por: Huggins, David J., et al.
Publicado: (2012)

GPCR Conformations: Implications for Rational Drug Design
por: Parrill, Abby L., et al.
Publicado: (2010)

Computational Methods Applied to Rational Drug Design
por: Ramírez, David
Publicado: (2016)

Rationally Designed DNA Nanostructures for Drug Delivery
por: Xu, Fan, et al.
Publicado: (2020)

Rationality over fashion and hype in drug design
por: Medina-Franco, José L., et al.
Publicado: (2021)

Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: A Computational drug design approach
por: Akash, Shopnil, et al.
Publicado: (2023)

A comprehensive study of SARS-CoV-2 main protease (M(pro)) inhibitor-resistant mutants selected in a VSV-based system
por: Costacurta, Francesco, et al.
Publicado: (2023)

Enhancement of Proteolytic Activity of a Thermostable Papain-Like Protease by Structure-Based Rational Design
por: Dutta, Sruti, et al.
Publicado: (2013)

A new inactive conformation of SARS‐CoV‐2 main protease
por: Fornasier, Emanuele, et al.
Publicado: (2022)

Corrigendum: Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: a computational drug design approach
por: Akash, Shopnil, et al.
Publicado: (2023)

A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox
por: Hung, Yuan-Pin, et al.
Publicado: (2022)

Lessons Learnt from COVID-19: Computational Strategies for Facing Present and Future Pandemics
por: Pavan, Matteo, et al.
Publicado: (2023)

On the Rational Drug Design for Hypertension through NMR Spectroscopy
por: Chontzopoulou, Eleni, et al.
Publicado: (2020)

Rational design of yolk–shell nanostructures for drug delivery
por: Mohammadi Ziarani, Ghodsi, et al.
Publicado: (2020)

Rational design of a new mutant of tobacco etch virus protease in order to increase the in vitro solubility
por: Mohammadian, Hossein, et al.
Publicado: (2020)

Rational Drug Design of Axl Tyrosine Kinase Type I Inhibitors as Promising Candidates Against Cancer
por: Sarukhanyan, Edita, et al.
Publicado: (2020)

Rational design and synthesis of novel phenylsulfonyl-benzamides as anti-prostate cancer agents
por: Bassetto, Marcella, et al.
Publicado: (2017)

Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy
por: Chiang, Austin W. T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5lsioqncnr8i110p14un4cqa05